Novavax Inc (NVAX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Novavax inc   (NASDAQ: NVAX)
 

Novavax Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novavax Inc 's inventory turnover ratio, the ratio that measures Novavax Inc 's ability to manage its supply chain, sequentially decreased to 7.61 in the second quarter 2026, which does not come as a surprise, as the Novavax Inc continue to experience headwinds, which also impact its supply chain. Average processing period, for Novavax Inc 's inventories remained unchanged at 48 days, in the Jun 30 2026 quarter.

Within Healthcare sector 49 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 284 in the first quarter 2026, to 512.

NVAX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novavax Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVAX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -2.29 % 11.64 % 31.96 % 56.41 % 11.64 %
Y / Y Cost of Sales Growth -7.04 % 117.46 % -39.72 % -64.54 % -66.86 %
Inventory Turnover Ratio (TTM) 7.61 7.67 6.41 8.19 13.38
NVAX's Total Ranking # 512 # 284 # 457 # 279 # 233
Average inventory processing period 48 48 57 45 27
Seq. Inventory Growth -12.67 % -0.75 % -14.55 % 31.94 % -0.22 %
Seq. Cost of Sales Growth -53.59 % 38.87 % 2.83 % 40.27 % 8.57 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 50
Overall Market # 512

Inventory Turnover Ratio Statistics
High Average Low
19.15 11.11 6.41
(Dec 31 2024)   (Dec 31 2025)



NVAX Company Profile >> Back to NVAX Efficiency Comparisons >> Compare NVAX Inventory Turnover Ratio to its Competitors

Financial Statements
Novavax Inc 's Inventories $ 10 Millions Visit NVAX's Balance sheet
Novavax Inc 's Cost of Revenues TTM $ 89 Millions Visit NVAX's Income Statement
What are NVAX's Sales? Visit NVAX's Sales by Segment

Other Inventory Turnover Ratios
Novavax Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVAX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVAX's Competitors
Inventory Turnover Ratio for NVAX's Suppliers
Inventory Turnover Ratio for NVAX's Customers

You may also want to know
NVAX's Sales Growth Rates NVAX's Pe Price to earnings ratio NVAX's Receivables Turnover Ratio NVAX's Stock Quote
NVAX's Net Income Growth Rates NVAX's Ps Price to Sales ratio NVAX's Sales per Employee NVAX's Asset Turnover Ratio
NVAX's Net Margin NVAX's Pb Price to Book ratio NVAX's Financial Strength Ratios NVAX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Adapthealth Corp   20.25 $ 2,676.899  Millions$ 132  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.